Port Matilda, Pennsylvania, April 15, 2013 - At an event held on Tuesday evening, April 9, 2013, at the Hershey Lodge and Convention Center in Hershey, Pennsylvania, QBC Diagnostics/Drucker Company received the award for Technology Leader of the Year from the Technology Council of Pennsylvania.

This annual award ceremony, The PA Tech Awards Celebration, recognizes the technology "game changers" in the region. The Technology Leader of the Year Award is presented to a company CEO who has demonstrated a prolonged, strong commitment to advancing the growth and development of the technology industry in Pennsylvania. Ken Moscone, CEO of QBC Diagnostics/Drucker Company, said, "Our team at QBC/Drucker is honored to receive this recognition. Our growth as a company is the result of the hard work of all our employees coupled with the support of organizations such as the Tech Council and Ben Franklin Technology Partners."

Stephen Brawley, President & CEO of Ben Franklin Technology Partners/CNP, who was also one of the evening's award presenters, commented, "To even be nominated for this prestigious award, you need to have a proven track record of substantial contributions to the technology industry, a history of outstanding leadership in advancing the growth and development of technology, and a high level of respect from industry peers. These criteria describe the company's CEO, Ken Moscone, perfectly."

The Drucker Company, a long-time manufacturer of general purpose and clinical centrifuges, developed the Horizon line of centrifuges, which with its patented, horizontal rotor design, decreases processing time, is easy to use and assures repeatable, reproducible, and high quality analytic results. Now, with 19 different centrifuge models currently offered, The Drucker Company continues to pioneer affordable and reliable products from its facilities in Philipsburg and Port Matilda.

Nearly eight years ago, the Drucker Company purchased the hematology business from a leading multinational diagnostic equipment company, and formed QBC Diagnostics. The core technology is a patented technique in which a small sample of whole blood is placed into a capillary tube and centrifuged at high speed until all of the blood's components are separated according to their specific gravity. The QBC technology enables physicians to quickly and easily perform a Complete Blood Count (CBC) at the point of care.

More recently, QBC Diagnostics expanded its product line to include cutting-edge fluorescence microscopy products. The ParaLens Advance microscope attachment uses a bright, durable LED light source to easily and affordably transform any compound light microscope into a fluorescence microscope. This innovation has allowed the company to provide rapid, sensitive fluorescent staining and processing equipment that helps detect infectious diseases such as malaria and tuberculosis.